FFA
Fragasso Financial Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270K | Buy |
6,658
+16
| +0.2% | +$649 | 0.02% | 237 |
|
|
2025
Q1 | $291K | Buy |
6,642
+23
| +0.3% | +$1.01K | 0.02% | 220 |
|
|
2024
Q4 | $285K | Buy |
6,619
+24
| +0.4% | +$1.03K | 0.02% | 215 |
|
|
2024
Q3 | $293K | Sell |
6,595
-409
| -6% | -$18.1K | 0.02% | 211 |
|
|
2024
Q2 | $279K | Sell |
7,004
-4
| -0.1% | -$159 | 0.02% | 217 |
|
|
2024
Q1 | $302K | Buy |
7,008
+6
| +0.1% | +$259 | 0.03% | 205 |
|
|
2023
Q4 | $291K | Sell |
7,002
-1,073
| -13% | -$44.7K | 0.03% | 208 |
|
|
2023
Q3 | $321K | Hold |
8,075
| – | – | 0.03% | 183 |
|
|
2023
Q2 | $331K | Buy |
8,075
+159
| +2% | +$6.52K | 0.04% | 185 |
|
|
2023
Q1 | $325K | Buy |
7,916
+1,416
| +22% | +$58.1K | 0.04% | 170 |
|
|
2022
Q4 | $266K | Buy |
+6,500
| New | +$266K | 0.03% | 178 |
|